Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients: A prospective study

Transplantation

Volumn 63, Issue 3, 1997, Pages 380-386

  Aroldi, Adriana ^a,b   Tarantino, Antonio ^a   Montagnino, Giuseppe ^a   Cesana, Bruno ^a   Cocucci, Carlo ^c   Ponticelli, Claudio ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b Divisione Di Nefrologia   (Italy)

^c PARKINSON INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; OKT 3; STEROID;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; OSTEOPENIA; PREMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRABECULAR BONE;

ADULT; BONE DENSITY; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SEX FACTORS;

EID: 0031016377     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199702150-00009     Document Type: Article

References (21)

1. Reid IR, Veale AG, France JT. Glucocorticoid osteoporosis. J Asthma 1994; 31: 7.
2. Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S. Cyclosporine-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinology 1988; 123: 2571.
3. Cvetkovic M, Mann GN, Romero DF, et al. The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo. Transplantation 1994; 57: 1231.
4. Bryer HP, Isserow JA, Armstrong EC, et al. Azathioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat. J Bone Miner Res 1995; 10: 132.
5. Dumoulin, Hory B, Nguyen NU, et al. Lack of evidence that cyclosporine treatment impairs calcium-phosphorus homeostasis and bone remodeling in normocalcemic long-term renal transplant recipients. Transplantation 1995; 59: 1690.
6. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991; 325: 544.
7. Wolpaw T, Deal CL, Fleming-Brooks S, Bartucci MR, Schulak J, Hricik DE. Factors influencing vertebral bone density after renal transplantation. Transplantation 1994; 58: 1186.
8. Grotz W, Mundinger A, Gugel B, Exner V, Reichelt A, Schollmeyer P. Missing impact of cyclosporine on osteoporosis in renal transplant recipients. Transplant Proc 1994; 26: 2652.
9. Draper N, Smith H. Applied regression analysis, 2nd ed. New York: J. Wiley & Sons, Inc., 1981.
10. Kirk RE. Experimental design, 2nd ed. Procedure for the behavioral science. Belmont: Brooks Cole Publishing Co., 1982: chap. 14, 715.
11. Almond MK, Kwan JT, Evans K, Cunningham J. Loss of regional bone mineral density in the first 12 months following renal transplantation. Nephron 1994; 66: 52.
12. Torregrosa JV, Campistol JM, Montesinos M, et al. Factors involved in the loss of bone mineral density after renal transplantation. Transplant Proc 1995; 27: 2224.
13. Aubia J, Masramon J, Serrano S, Lloveras J, Marinoso L. Bone histology in renal transplant patients receiving cyclosporin. Lancet 1988; i: 1048.
14. Grotz WH, Mundinger FA, Rasenack J, et al. Bone loss after kidney transplantation: a longitudinal study in 115 graft recipients. Nephrol Dial Transplant 1995; 10: 2096.
15. Briner VA, Thiel G, Monier-Faugere MC, et al. Prevention of cancellous bone loss but persistence of renal bone disease despite normal 1,25 vitamin D levels two years after kidney transplantation. Transplantation 1995; 59: 1393.
16. Loertscher R, Thiel G, Harder F, Brunner FP. Persistent elevation of alkaline phosphatases in cyclosporine-treated renal transplant recipients. Transplantation 1983; 36: 115.
17. Grotz WH, Mundinger FA, Gugel B, Exner VM, Kirste G, Schollmeyer PJ. Bone mineral density after kidney transplantation: a cross-sectional study in 190 graft recipients up to 20 years after transplantation. Transplantation 1995; 59: 982.
18. Chan TM, Pun KK, Cheng IKP. Total and regional bone densities in dialysis patients. Nephrol Dial Transplant 1992; 7: 835.
19. Grotz WH, Mundinger FA, Gugel B, Exner V, Kirste G, Schollmeyer PJ. Bone fracture and osteodensitometry with dual energy x-ray absorption in kidney transplant recipients. Transplantation 1994; 58: 912.
20. Tarantino A, Aroldi A, Stucchi L, et al. A randomized prospective trial comparing cyclosporine monotherapy with triple drug therapy in renal transplantation. Transplantation 1991; 52: 53.
21. Hricik DE, O'Toole MA, Schulak JA, Herson J. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol 1993; 4: 1300.